Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
25
27
28
29
1
3
5
6
7
8
11
13
15
17
18
19
20
21
22
24
25
27
28
29
31
1
2
3
4
5
3rd International conference on  Diabetes, Hypertension and Metabolic Syndrome
2020-02-24 - 2020-02-25    
All Day
About Diabetes Meet 2020 Conference Series takes the immense Pleasure to invite participants from all over the world to attend the 3rdInternational conference on Diabetes, Hypertension and [...]
3rd International Conference on Cardiology and Heart Diseases
2020-02-24 - 2020-02-25    
All Day
ABOUT 3RD INTERNATIONAL CONFERENCE ON CARDIOLOGY AND HEART DISEASES The standard goal of Cardiology 2020 is to move the cardiology results and improvements and to [...]
Medical Device Development Expo OSAKA
2020-02-26 - 2020-02-28    
All Day
ABOUT MEDICAL DEVICE DEVELOPMENT EXPO OSAKA What is Medical Device Development Expo OSAKA (MEDIX OSAKA)? Gathers All Kinds of Technologies for Medical Device Development! This [...]
Beauty Care Asia Pacific Summit 2020 (BCAP)
2020-03-02 - 2020-03-04    
All Day
Groundbreaking Event to Address Asia-Pacific’s Growing Beauty Sector—Your Window to the World’s Fastest Growing Beauty Market The international cosmetics industry has experienced a rapid rise [...]
IASTEM - 789th International Conference On Medical, Biological And Pharmaceutical Sciences ICMBPS
2020-03-04 - 2020-03-05    
All Day
IASTEM - 789th International Conference on Medical, Biological and Pharmaceutical Sciences ICMBPS will be held on 4th - 5th March, 2020 at Hamburg, Germany . [...]
Global Drug Delivery And Formulation Summit 2020
2020-03-09 - 2020-03-11    
All Day
Innovative solutions to the greatest challenges in pharmaceutical development. Price: Full price delegate ticket: GBP 1495.0. Time: 9:00 am to 6:00 pm About Conference KC [...]
Inborn Errors Of Metabolism Drug Development Summit 2020
2020-03-10 - 2020-03-12    
All Day
Confidently Translate, Develop and Commercialize Gene, mRNA, Replacement Therapies, Small Molecule and Substrate Reduction Therapies to More Efficaciously Treat Inherited Metabolic Diseases. Time: 8:00 am [...]
Texting And E-Mail With Patients: Patient Requests And Complying With HIPAA
2020-03-12    
All Day
Overview:  This session will focus on the rights of individuals to communicate in the manner they desire, and how a medical office can decide what [...]
14 Mar
2020-03-14 - 2020-03-21    
All Day
Topics in Family Medicine, Hematology, and Oncology CME Cruise. Prices: USD 495.0 to USD 895.0. Speakers: David Parrish, MS, MD, FAAFP, Alexander E. Denes, MD, [...]
International Conference On Healthcare And Clinical Gerontology ICHCG
2020-03-14 - 2020-03-15    
All Day
An elegant and rich premier global platform for the International Conference on Healthcare and Clinical Gerontology ICHCG that uniquely describes the Academic research and development [...]
World Congress And Expo On Cell And Stem Cell Research
2020-03-16 - 2020-03-17    
All Day
"The world best platform for all the researchers to showcase their research work through OralPoster presentations in front of the international audience, provided with additional [...]
25th International Conference on  Diabetes, Endocrinology and Healthcare
2020-03-23 - 2020-03-24    
All Day
About Conference: Conference Series LLC Ltd is overwhelmed to announce the commencement of “25th International Conference on Diabetes, Endocrinology and Healthcare” to be held during [...]
ISN World Congress of Nephrology 2020
2020-03-26 - 2020-03-29    
All Day
ABOUT ISN WORLD CONGRESS OF NEPHROLOGY 2020 ISN World Congress of Nephrology (WCN) takes place annually to enable this premier educational event more available to [...]
30 Mar
2020-03-30 - 2020-03-31    
All Day
This Cardio Diabetes 2020 includes Speaker talks, Keynote & Poster presentations, Exhibition, Symposia, and Workshops. This International Conference will help in interacting and meeting with diabetes and [...]
Trending Topics In Internal Medicine 2020
2020-04-02 - 2020-04-04    
All Day
Trending Topics in Internal Medicine is a CME course that will tackle the latest information trending in healthcare today.   This course will help you discuss options [...]
2020 Summit On National & Global Cancer Health Disparities
2020-04-03 - 2020-04-04    
All Day
The 2020 Summit on National & Global Cancer Health Disparities is planned with the goal of creating a momentum to minimize the disparities in cancer [...]
Events on 2020-02-26
Events on 2020-03-02
Events on 2020-03-09
Events on 2020-03-10
Events on 2020-03-16
Events on 2020-03-26
Events on 2020-03-30
Events on 2020-04-02
Events on 2020-04-03
Latest News

Should CMS Nix Stage 2 Meaningful Use Patient Engagement

healthcare organizations

Are the patient engagement requirements in Stage 2 meaningful use just too hard for providers to achieve?  CMS seems to think so.  Healthcare organizations are finding the five percent patient engagement threshold to be a stumbling block for Stage 2 attestation, the agency says in a new proposed rule that would make significant changes to the EHR Incentive Programs, and cutting the requirement would help more organizations successfully attest and avoid negative payment adjustments.

The five percent patient engagement measure has always been a worry for providers who dislike the idea of being held financially accountable for what patients do on their own time.  While many providers have successfully cajoled their patients into viewing, downloading, or transmitting their personal health information through patient portals, others have told CMS neither the technology nor the interest are sufficient to clear the bar.

“Providers and system developers have noted…an overall immaturity in the market with health IT equipped with the functions required to support the transmission of health information by a patient or the delivery of a secure message from a patient to a third party,” the proposed rule says.

Instead of pinning patient engagement at five percent, the new regulations would only require eligible providers to record one single patient viewing or transmitting their health data during their reporting period in order to meet the objective.  Eligible hospitals would need to do the same for just one discharged patient.  Instead of a five percent threshold for secure messaging, providers would simply have to prove that they had the ability to send and receive messages enabled during their reporting period.

This would require providers to implement basic patient engagement technologies, but would not place an undue burden on workflows or patient education for those organizations that have challenging populations to work with.

Many organizations have noted that the patients who would most benefit from becoming more engaged in their own healthcare, such as low-income populations who are prone to chronic diseases, poor health literacy, and uncertain access to the healthcare system, lack critical tools like reliable home internet access or smartphones that make patient engagement easier for more tech-savvy consumers.

Other advocates note that the all-or-nothing threshold does not take into account improvement over time or the effort it takes to get most of the way to the finish line.  Robert Tennant, Senior Policy Advisor at the Medical Group Management Association (MGMA), recalls testimony from a recent Senate hearing on health IT progress.

“One of the witnesses, who owns a small family practice in Nebraska, said he only had two hours to go before the reporting deadline, and they were two patients short of meeting their secure messaging threshold,” Tennant told HealthITAnalytics.com.  “So he had to call up these two patients and essentially beg them to send a message, even if it was something irrelevant like the scores to a basketball game.”

“You take a step back and it’s kind of funny, but also it’s disconcerting that the whole point of this program, which is to provide better quality care to patients, isn’t helping us find that,” he added.  “We’re finding that physicians are checking boxes, trying to meet the requirements to avoid getting penalized, and that is simply wrong.”

CHIME and AMDIS expressed similar concerns, condemning the strict yes-or-no framework that has been so challenging to providers during Stage 2.  “We are disappointed by a missed opportunity to remove the largest remaining barrier to long-term programmatic success: namely, the need to address the program’s “pass/fail” construct,” the two organizations said in a joint statement.

“Now that we are well into the penalty phase of the program, we do not believe providers who make good-faith efforts should be penalized for missing 1 percent on one threshold. Rather, policymakers should acknowledge providers who invest resources to become meaningful users, but fall short of perfection, by limiting penalties to those providers who clearly did not make the effort.”

CMS is using the modification as a way to acknowledge that something is amiss with the way patient engagement is included in meaningful use.  “We believe these changes would allow providers the necessary time to work toward patient education about the availability of these resources as well as allowing the industry as a whole time to develop a stronger infrastructure supporting patient engagement,” the rule says.

However, some patient engagement advocates immediately expressed their displeasure with the suggestion that engagement is somehow less important to meaningful use than any of the other, unchanged measures.  Patient engagement is seen as a key part of achieving the Triple Aim, and has been heavily stressed up until this point as a way to manage population health and reduce the costs of chronic disease management.

Former ONC chief Dr. Farzad Mostashari, a stalwart proponent of patient engagement, lashed out at the suggestion during a pre-conference session at HIMSS15.  “For the first time, I’m taking issue” with a meaningful use rule, he said.  “I think we need to show the policymakers that they’re not just pushing rope here. We need to show that there’s demand.”  Mostashari and others are planning a “day of action” that will try to show regulators that patients themselves are eager to get involved with their own care, and that the healthcare system is responsible for providing the tools, expertise, and commitment to allow them to do so.

“Patients are not an advocacy group,” he said. “They are not a special interest. They’re why we do this.”  The theme is likely to be repeated as the 60-day comment period for the proposed changes opens up this week.  A group called the Alliance4Health has opened a petition on Change.org to urge CMS to reconsider its ruling, noting how patient engagement can reduce data integrity errors, increase patient safety, and keep the channels of communication open between caregivers, patients, and providers.

“Patients are critical members of their own care teams and we need full and equal access to same health data that everyone else on our care team has and much of that information is now contained in EHRs,” the petition says.

CMS and the ONC don’t disagree with that premise, countered current National Coordinator Dr. Karen DeSalvo in a media briefingat HIMSS15. “Our commitment to consumers and free access to their health information is unwavering.  It is thematic and central for me as a doctor and as a person that the control is meaningful and that they are able to be engaged not just by looking, but by having bi-directional engagement with the record.”

“What’s really exciting about the last few days is the dialogue that’s ensued and what’s going to be essential is that advocacy representatives for consumers sit down and talk with providers to understand technology and cultural challenges,” said DeSalvo. “What we need to do is to find some shared solutions and they probably exist technologically today. Some of this is also about culture. The dialogue is good, and I think it’s gotten a lot of important attention. We need to find out the right path for it.”

The drastic reduction in Stage 2 does not bode well for the 25 percent threshold included in the Stage 3 meaningful use rule, which was instantly viewed with skepticism upon release.  Will Stage 3 see a similar downgrade before 2018 rolls around?  Or will CMS take into account ongoing gripes about the “check box” mentality of the EHR Incentive Programs and overhaul the requirements all together, allowing providers to submit their progress and efforts as proof that they are taking patient engagement seriously?

Healthcare stakeholders who wish to submit their opinions on the issue may do so during the 60-day open comment period by clicking here.

Source